MOSCOW (JAPAN) – According to the reports, doses of Russia’s Sputnik V vaccine against COVID-19 will not be available in the market until at least late 2021. The vaccines produced in Italy by Swiss-based pharmaceutical company Adienne Pharma & Biotech will need approval from Italian regulators before production can be launched.
The company said it had also struck deals with production facilities in Spain, France, and Germany.
The production agreements are the latest indication that some companies could press ahead with plans without waiting for the European Union’s regulator, the European Medicines Agency (EMA), to grant its approval to Sputnik V.
President of Lugano-based Adienne, Antonio Francesco Di Naro said, “The company will not produce batches for sale until late 2021.”
Di Naro added the company still needed to complete the process of exchanging technology to produce Sputnik V, test its production, and transfer data to national regulators before the shot could go on sale.